We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

131 hedge funds and large institutions have $645M invested in Arena Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 31 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 31

3% more capital invested

Capital invested by funds: $629M → $645M (+$15.9M)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 134 → 131 (-3)

46% less call options, than puts

Call options by funds: $29.8M | Put options by funds: $54.7M

Holders
131
Holders Change
-3
Holders Change %
-2.24%
% of All Funds
3.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
48
Reduced
31
Closed
22
Calls
$29.8M
Puts
$54.7M
Net Calls
-$24.9M
Net Calls Change
+$1.98M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$6.63M
2
Goldman Sachs
Goldman Sachs
New York
+$5.93M
3
Invesco
Invesco
Georgia
+$4.16M
4
CA
Commerzbank Aktiengesellschaft
Germany
+$2.42M
5
Morgan Stanley
Morgan Stanley
New York
+$2.33M

Top Sellers

Rank Fund Capital Flow
1
SC
Samlyn Capital
New York
-$21.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$4.12M
4
VanEck Associates
VanEck Associates
New York
-$3.44M
5
CS
Credit Suisse
Switzerland
-$3.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
51
AQR Capital Management
Connecticut
$779K – – –
Group One Trading
52
Group One Trading
Illinois
$725K +$763K +11,506 New
TMAM
53
Tokio Marine Asset Management
Japan
$625K – – –
Millennium Management
54
Millennium Management
New York
$562K +$592K +8,918 New
Citadel Advisors
55
Citadel Advisors
Florida
$547K -$1.49M -22,423 -72%
LPL Financial
56
LPL Financial
California
$541K +$13.5K +203 +2%
UBS AM
57
UBS AM
Illinois
$530K – – –
NPC
58
National Planning Corporation
California
$498K +$57.4K +865 +13%
Janney Montgomery Scott
59
Janney Montgomery Scott
Pennsylvania
$449K -$3.32K -50 -0.7%
Principal Financial Group
60
Principal Financial Group
Iowa
$446K +$69.1K +1,042 +17%
Cambridge Investment Research Advisors
61
Cambridge Investment Research Advisors
Iowa
$424K +$6.63K +100 +2%
Fidelity Investments
62
Fidelity Investments
Massachusetts
$374K – – –
Citigroup
63
Citigroup
New York
$370K -$480K -7,237 -55%
LWM
64
Lyons Wealth Management
Florida
$359K – – –
T. Rowe Price Associates
65
T. Rowe Price Associates
Maryland
$350K – – –
ACI
66
Alpha Cubed Investments
California
$320K +$5.04K +76 +2%
AG
67
Aperio Group
California
$319K +$336K +5,057 New
HK
68
Horizon Kinetics
New York
$284K – – –
MCM
69
Murphy Capital Management
New Jersey
$283K – – –
Two Sigma Investments
70
Two Sigma Investments
New York
$271K +$212K +3,188 +286%
HNB
71
Huntington National Bank
Ohio
$252K +$265K +4,000 New
CCMH
72
Cornerstone Capital Management Holdings
New York
$248K +$261K +3,930 New
U
73
UBS
Switzerland
$243K -$131K -1,970 -34%
Wells Fargo
74
Wells Fargo
California
$214K -$128K -1,935 -36%
WMSA
75
Weiss Multi-Strategy Advisers
New York
$214K +$2.72K +41 +1%
1 2
3
4 5

ARNA Hedge Fund Activity: Q1 2014 in Review

131 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2014, worth a combined $645M — up 2.5% from $629M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ARNA and 21 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 48 added.

The largest buyer was OppenheimerFunds, adding an estimated $6.63M. The largest seller was Samlyn Capital, exiting entirely with an estimated $21.4M sold.

  • 131 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2014, down from 134 in Q4 2013.
  • Funds reported $645M of Arena Pharmaceuticals Inc stock for Q1 2014, up 2.5% quarter-over-quarter.
  • 21 funds opened new Arena Pharmaceuticals Inc positions in Q1 2014 and 22 closed out, a net change of -1 holder.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2014 was OppenheimerFunds, an estimated $6.63M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2014 was Samlyn Capital, an estimated $21.4M sold.

Based on aggregated 13F filings for Q1 2014.